2023-09-15T06:14:19+03:00[Europe/Moscow] en true <p>prevention of hospitalizations/reduce mortality, control symptoms, and provide optimal patient education</p>, <p>control HR, BP, fluid volume </p>, <p>loop diuretics, digoxin, ivabradine </p>, <p>fluid/ sodium restrictoin </p>, <p>c</p>, <p>d</p>, <p>a,b</p>, <p>f; used for symptom control </p>, <p>renal function &amp; electrolytes </p>, <p>MRA + loop or ACE/ARB/ARNI + loop </p>, <p>b</p>, <p>c</p>, <p>b</p>, <p>to keep people out of hospital/ED</p>, <p>e</p>, <p>f</p>, <p>as needed for unresponsive edema </p>, <p>30 min before loop; takes longer to peak</p>, <p>in HF, high amount of sodium reaches distal collecting tubule; this combination reduces this </p>, <p>increase dose, change loops, add thiazide/mra, split doses, enhance TLC</p>, <p>CV safety </p>, <p>lower preload, afterload, and remodeling </p>, <p>CrCl &lt; 25 ml/min </p>, <p>in am due to diuresis </p>, <p>f; most ae's are seen in diabetics </p>, <p>2 L of water; 2 gm of salt </p>, <p>BMP, weight, kidneys</p>, <p>increased glucagon; serves as alternate energy source increasing CO, HR, and blood flow</p>, <p>inhibit myocardium na/h exhanger; decreases fibrosis/remodeling</p>, <p>metoprolol succinate, bisoprolol, carvedilol, nebivolol </p>, <p>b,c </p>, <p>a</p>, <p>d</p>, <p>a</p>, <p>b</p>, <p>&lt; 1 ng/mL </p>, <p>60-80% bioavailability, 25% protein binding; no fat distribution, low liver metabolism, p-glycoprotein substrate, long half-life, excreted highly unchanged</p>, <p>thiazides, MRAs, macrolides</p>, <p>antacids, st. john's wort</p>, <p>BBs, CCBs, calcium</p>, <p>thyroid hormones, high fiber diet </p>, <p>6 hours post dose</p>, <p>f; can happen w acute ingestion too</p>, <p>low k+/Mg, dehydration, drug interactions, kidney dysfunction </p>, <p>hold/reduce dose, activated charcoal, gastric lavage, DigiFab</p>, <p>yearly, changes in renal function, changes to interacting drugs</p>, <p>5 mg BID w food; titrate to resting HR of 50-60 bpm; max 7.5 mg BID</p>, <p>bradycardia/heart block, pacemaker dependency, CYP3A4 inhibitors, severe hepatic impairment </p>, <p>f; very expensive</p>, <p>patient must be on max tolerated BB, EF &lt;=35%, NYHA class II-IV symptoms, normal sinus rhythm, HR &gt; 70</p>, <p>EF &lt;=40%; class II-IV</p>, <p>current ACEI/ARB dose, renal &amp; hepatic function</p>, <p>36 hr; 24 hr</p>, <p>f; AA only</p>, <p>BID-TID; 5-6 tabs</p>, <p>when an AA patient can't take an ACEi/ARB</p>, <p>f; HF max dose is 400 mg</p>, <p>no generic; most insurance won't cover without a PA</p>, <p>SrCr &gt;= 2.5, GFR &lt; 30, K+ &gt;= 5</p>, <p>3 days--&gt; 7 days--&gt; monthly for 1st 3 months at initiation/dose changes</p>, <p>symptomatic HF; EF &lt; 45%</p>, <p>pregnancy; contraception required</p>, <p>BP, CBC, pregnancy</p>, <p>farxiga; jardiance </p>, <p>patients w frequent hospitalizations/symptoms </p> flashcards
HF Therapeutic Management ( Outpatient )

HF Therapeutic Management ( Outpatient )

  • prevention of hospitalizations/reduce mortality, control symptoms, and provide optimal patient education

    What are the goals of of HF therapy? (3)

  • control HR, BP, fluid volume

    What are the three pillars of medication therapy in HF?

  • loop diuretics, digoxin, ivabradine

    Which drugs don't decrease mortality? (3)

  • fluid/ sodium restrictoin

    What are the two most important things in HF lifestyle changes?

  • c

    Which is the diuretic of choice?

    a) thiazides

    b) AA/MRAs

    c) loop diuretics

    d) metolazone

  • d

    Which is extremely potent and used in acute treatment?

    a) thiazides

    b) AA/MRAs

    c) loop diuretics

    d) metolazone

  • a,b

    Which are mostly adjunctive?

    a) thiazides

    b) AA/MRAs

    c) loop diuretics

    d) metolazone

  • f; used for symptom control

    Loop diuretics have been proven to lower mortality. T/F?

  • renal function & electrolytes

    What are the main monitoring points for Loop diuretics? (2)

  • MRA + loop or ACE/ARB/ARNI + loop

    Which combo of medications used in conjunction with Loops can worsen renal function?

  • b

    Which is the only "true" once daily?

    a) bumetadine

    b) torsemide

    c) furosemide

    d) ethacrynic acid

    e) furoscix

    f) metalozone

  • c

    Which needs to be taken with food?

    a) bumetadine

    b) torsemide

    c) furosemide

    d) ethacrynic acid

    e) furoscix

    f) metalozone

  • b

    Which has the most predictable kinetics?

    a) bumetadine

    b) torsemide

    c) furosemide

    d) ethacrynic acid

    e) furoscix

    f) metalozone

  • to keep people out of hospital/ED

    Why do we give people Furoscix, On-Body Infuser?

  • e

    Which CANNOT be used in an emergency situation?

    a) bumetadine

    b) torsemide

    c) furosemide

    d) ethacrynic acid

    e) furoscix

    f) metalozone

  • f

    Which has the longest half-life?

    a) bumetadine

    b) torsemide

    c) furosemide

    d) ethacrynic acid

    e) furoscix

    f) metalozone

  • as needed for unresponsive edema

    Why is Metolazone prescribed?

  • 30 min before loop; takes longer to peak

    When do we give patients Metolazone?

  • in HF, high amount of sodium reaches distal collecting tubule; this combination reduces this

    Why do we give patients thiazides + loops?

  • increase dose, change loops, add thiazide/mra, split doses, enhance TLC

    How can we combat diuretic resistance? (5)

  • CV safety

    All diabetes medications have to be assessed for ________.

  • lower preload, afterload, and remodeling

    How do SGLT2 inhibitors help with HF?

  • CrCl < 25 ml/min

    When do we avoid SGLT2 inhibitors?

  • in am due to diuresis

    When do we give patients SGLT2 inhibitors?

  • f; most ae's are seen in diabetics

    SGLT2 inhibitors cause AE's in all patients. T/F?

  • 2 L of water; 2 gm of salt

    How much fluid can HF patients have daily? How much sodium?

  • BMP, weight, kidneys

    What do we have to monitor in patients on Metolazone? (3)

  • increased glucagon; serves as alternate energy source increasing CO, HR, and blood flow

    How do SGLT-2 inhibitors affect metabolism?

  • inhibit myocardium na/h exhanger; decreases fibrosis/remodeling

    How do SGLT-2 inhibitors affect the heart directly?

  • metoprolol succinate, bisoprolol, carvedilol, nebivolol

    Which BB's have been proven to reduce mortality & morbidity? (4)

  • b,c

    Which are better at reducing HR?

    a) carvedilol

    b) metoprolol succinate

    c) bisoprolol

    d) nebivolol

  • a

    Which is better at reducing BP?

    a) carvedilol

    b) metoprolol succinate

    c) bisoprolol

    d) nebivolol

  • d

    Which is equally efficacious in reducing HR & BP?

    a) carvedilol

    b) metoprolol succinate

    c) bisoprolol

    d) nebivolol

  • a

    Which has to be taken with food?

    a) carvedilol

    b) metoprolol succinate

    c) bisoprolol

    d) nebivolol

  • b

    Which can be split?

    a) carvedilol

    b) metoprolol succinate

    c) bisoprolol

    d) nebivolol

  • < 1 ng/mL

    What is our target serum levels in Digoxin?

  • 60-80% bioavailability, 25% protein binding; no fat distribution, low liver metabolism, p-glycoprotein substrate, long half-life, excreted highly unchanged

    Digoxin Kinetics? (6)

  • thiazides, MRAs, macrolides

    Which medications can INCREASE Digoxin concentrations? (3)

  • antacids, st. john's wort

    Which medications can DECREASE Digoxin concentrations? (2)

  • BBs, CCBs, calcium

    Which medications can INCREASE Digoxin therapeutic effects? (3)

  • thyroid hormones, high fiber diet

    What can DECREASE Digoxin therapeutic effects? (2)

  • 6 hours post dose

    When should we draw a patient's Digoxin levels?

  • f; can happen w acute ingestion too

    Digoxin toxicity can only occur with chronic ingestion. T/F?

  • low k+/Mg, dehydration, drug interactions, kidney dysfunction

    What are the predisposing factors that make someone more likely to

    experience Digoxin toxicity? (4)

  • hold/reduce dose, activated charcoal, gastric lavage, DigiFab

    How can we treat Digoxin toxicity? (4)

  • yearly, changes in renal function, changes to interacting drugs

    When do we check Digoxin levels? (3)

  • 5 mg BID w food; titrate to resting HR of 50-60 bpm; max 7.5 mg BID

    Ivabradine dosing?

  • bradycardia/heart block, pacemaker dependency, CYP3A4 inhibitors, severe hepatic impairment

    Contraindications of Ivabradine? (4)

  • f; very expensive

    Ivabradine is a relatively cheap medication. T/F?

  • patient must be on max tolerated BB, EF <=35%, NYHA class II-IV symptoms, normal sinus rhythm, HR > 70

    Ivabradine prescribing requirements? (5)

  • EF <=40%; class II-IV

    What EF & class must a patient be in to receive Entresto?

  • current ACEI/ARB dose, renal & hepatic function

    What is the starting dose based off of when prescribing Entresto? (2)

  • 36 hr; 24 hr

    How long is the washout period for an ACEI?

    How long for an ARB?

  • f; AA only

    BiDil showed reduction in mortality in all races/ethnicities. T/F?

  • BID-TID; 5-6 tabs

    How often do patients take BiDil? How many tabs?

  • when an AA patient can't take an ACEi/ARB

    When do we give a patient BiDil?

  • f; HF max dose is 400 mg

    Hydralazine's max dose is higher in HTN than HF. T/F?

  • no generic; most insurance won't cover without a PA

    What are socioeconomic concerns to consider when prescribing a patient on BiDil?

  • SrCr >= 2.5, GFR < 30, K+ >= 5

    When do we avoid MRAs/AAs in patients w HF? (3)

  • 3 days--> 7 days--> monthly for 1st 3 months at initiation/dose changes

    When do we check a patient's BMP when they are on an MRA/AA?

  • symptomatic HF; EF < 45%

    Vericiguat (Verguvo) is FDA approved in _________ & ________.

  • pregnancy; contraception required

    Contraindication w Vericiguat (Verquvo) ?

  • BP, CBC, pregnancy

    What do we monitor in patients on Verquvo? (3)

  • farxiga; jardiance

    ______ & _____ are the only 2 medications shown to lower BOTH mortality and morbidity across all LVEFs.

  • patients w frequent hospitalizations/symptoms

    Who does Verquvo benefit the most?